Treatment of Grammatical Time Marking in Post-Stroke Aphasia
Launched by UNIVERSITY OF NEUCHATEL · Dec 12, 2022
Trial Information
Current as of January 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have had an imaging-objectified stroke in adulthood that resulted in aphasia (fluent or non-fluent). The time between the stroke and participation in this study must be greater than 6 months.
- • Be a native French speaker or have excellent mastery of French.
- • Be between 18 and 75 years old.
- • Present grammatical tense marking disorders objectified by language evaluation (deficit scores on the "Batterie d'Évaluation de la Production Syntaxique" (BEPS) verb flexion task, Monetta et al., 2018; and/or on the "Test d'expression morpho-syntaxique fine" (T.E.M.F.) active sentence production subtask, Bernaert-Paul and Simonin, 2011).
- Exclusion Criteria:
- • Present chronic symptoms of a substance use disorder as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria.
- • Have significant uncorrected vision and/or hearing impairment.
- • Have significant impairments in oral/written comprehension.
- • Present apraxia of speech or a severe arthritic disorder
- • Present hemineglect
- • Present impaired judgment and discernment, objectified by a neuropsychological evaluation
About University Of Neuchatel
The University of Neuchâtel is a prestigious Swiss institution dedicated to advancing knowledge through innovative research and education. With a strong emphasis on interdisciplinary collaboration, the university is actively involved in clinical trials that aim to enhance healthcare outcomes and contribute to scientific understanding in various fields. Leveraging a robust network of researchers, healthcare professionals, and academic resources, the University of Neuchâtel is committed to conducting rigorous clinical studies that adhere to the highest ethical standards, ultimately striving to translate research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Neuchâtel, , Switzerland
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials